The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-5-guanidino-2-(5-methyl-2-((S)-3-methyl-1-(4-(trifluoromethyl)benzamido)butyl)oxazole-4-carboxamido)pentanoic acid ID: ALA3736337
PubChem CID: 127035108
Max Phase: Preclinical
Molecular Formula: C24H31F3N6O5
Molecular Weight: 540.54
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Cc1oc([C@H](CC(C)C)NC(=O)c2ccc(C(F)(F)F)cc2)nc1C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
Standard InChI: InChI=1S/C24H31F3N6O5/c1-12(2)11-17(32-19(34)14-6-8-15(9-7-14)24(25,26)27)21-33-18(13(3)38-21)20(35)31-16(22(36)37)5-4-10-30-23(28)29/h6-9,12,16-17H,4-5,10-11H2,1-3H3,(H,31,35)(H,32,34)(H,36,37)(H4,28,29,30)/t16-,17-/m0/s1
Standard InChI Key: HZZPWXWAJRDGNZ-IRXDYDNUSA-N
Molfile:
RDKit 2D
38 39 0 0 0 0 0 0 0 0999 V2000
4.6332 -7.5468 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5122 -8.7602 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0051 -8.6063 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.8856 -9.8217 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3785 -9.6679 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2589 -10.8833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7519 -10.7295 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6323 -11.9449 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.1252 -11.7911 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6152 -10.6957 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.8292 -12.7629 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.0222 -9.8556 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.1017 -6.1218 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.8912 -5.2578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8933 -3.7570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5951 -3.0039 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5973 -1.5031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6375 -0.9049 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.1959 -3.0115 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6747 -6.1134 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.1332 -7.5416 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2756 -11.1930 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4933 -3.7660 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4245 -8.5100 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5348 -3.1700 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4891 -4.9660 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5988 1.5004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5996 2.7004 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-3.6378 0.9001 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-3.6383 2.0999 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
7.9806 -12.1641 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.0822 -11.3185 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 22 1 1
4 5 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
9 11 2 0
2 12 2 0
1 13 1 0
13 14 2 0
14 15 1 0
15 16 1 0
16 17 1 0
17 18 2 0
15 19 1 1
20 14 1 0
21 20 1 0
1 21 2 0
19 23 1 0
17 24 1 0
21 25 1 0
23 26 1 0
23 27 1 0
24 28 2 0
28 29 1 0
29 30 2 0
30 31 1 0
31 32 2 0
32 24 1 0
33 34 1 0
33 35 1 0
33 36 1 0
30 33 1 0
22 37 2 0
22 38 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 540.54Molecular Weight (Monoisotopic): 540.2308AlogP: 2.97#Rotatable Bonds: 12Polar Surface Area: 183.43Molecular Species: ZWITTERIONHBA: 6HBD: 6#RO5 Violations: 2HBA (Lipinski): 11HBD (Lipinski): 7#RO5 Violations (Lipinski): 3CX Acidic pKa: 3.98CX Basic pKa: 11.77CX LogP: 0.64CX LogD: 0.64Aromatic Rings: 2Heavy Atoms: 38QED Weighted: 0.13Np Likeness Score: -0.60
References 1. Singh R, Reed AN, Chu P, Scully CC, Yau MK, Suen JY, Durek T, Reid RC, Fairlie DP.. (2015) Potent complement C3a receptor agonists derived from oxazole amino acids: Structure-activity relationships., 25 (23): [PMID:26522948 ] [10.1016/j.bmcl.2015.10.038 ]